Sophia Genetics

The latest release of Sophia AI merges imaging analysis with genomic medicine in pursuit of better diagnosis and treatment.

Sophia Genetics has received a CE-IVD mark for a sequencing-based test that, combined with data analytics, is meant to improve detection of leukemia.

Swiss genomic analytics and AI firm Sophia Genetics has closed on a $30 million Series D round, led by new investor Balderton Capital.

The Smarty Pants

A number of genomics companies have made Technology Review's list of smart companies.

Swiss informatics firm Sophia Genetics has moved into liquid biopsies with an update to its SOPHiA AI system, changing how clinicians treat some cancers.

Hospitals in Morocco, Cameroon, and South Africa recently adopted its SOPHiA artificial intelligence offering, the firm's first crop of African customers.

The Hereditary Cancer Solution combines target capture probes from Integrated DNA Technologies with specialized analytics developed by Sophia.

The partnership aims to improve cancer molecular profiling by combining Horizon's HDx reference standards with Sophia's artificial intelligence solution.

The companies will combine their respective technologies to provide an integrated analytical and next-generation sequencing sample preparation offering for cancer research.

The co-marketing arrangement will initially cover hospitals and laboratories in Europe, the Middle East, and Africa.


Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.